Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Internet-delivered Cognitive Behavioural Therapy for Adolescents With Anxiety

8 augusti 2018 uppdaterad av: Gerhard Andersson, Linkoeping University

Internet-delivered Cognitive Behavioural Therapy for Adolescents With Anxiety: A Factorial Design

The purpose of this study is to evaluate the effects of learning support and chat on treatment outcome in internet-administrated cognitive behaviour therapy (ICBT) for adolescents with anxiety.

Studieöversikt

Detaljerad beskrivning

The study is set up as a factorial design with two independent variables: 1: Learning support and 2: chat-sessions in real time. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Swedish.

Studietyp

Interventionell

Inskrivning (Faktisk)

120

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Linköping, Sverige
        • Linköping University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

15 år till 19 år (Barn, Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Be between the ages of 15-19 years old
  • Have symptoms of anxiety, anxiety disorder

Exclusion Criteria:

  • Suicidal ideation
  • Alcohol addiction
  • other major primary psychiatric disorder
  • Ongoing psychological treatment
  • recent (during last 4 weeks) change in psychiatric medication

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Faktoriell uppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: ICBT standard
Internet-based cognitive behavioural therapy with therapeutic guidance through mail
Internet-based cognitive behavioural therapy with therapeutic guidance through mail, 8 weeks.
Experimentell: ICBT chat
Internet-based cognitive behavioural therapy with therapeutic guidance through chat
Internet-based cognitive behavioural therapy with therapeutic guidance through chat, 8 weeks.
Experimentell: ICBT learning support
Internet-based cognitive behavioural therapy with learning support and therapeutic guidance through mail
Internet-based cognitive behavioural therapy with learning support and therapeutic guidance through mail, 8 weeks.
Experimentell: ICBT with learning support and chat
Internet-based cognitive behavioural therapy with learning support and therapeutic guidance through chat
Internet-based cognitive behavioural therapy with learning support and therapeutic guidance through chat, 8 weeks.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Beck Anxiety Inventory (BAI)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures clinical anxiety. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Beck Depression Inventory - II (BDI-II)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures clinical depression. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Penn State Worry Questionnaire for Children (PSWQ - C)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures the tendency of youth to engage in excessive, generalized and uncontrollable worry. Respondents rates each item on a 4-point Likert scale consisting of never (0), sometimes (1), often (2) and always (3). The scores from each item are summed together to yield a total score that ranges from 0-42, with higher scores reflecting higher levels of worry. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Generalised Anxiety Disorder (GAD-7)
Tidsram: First week of treatment and then once a week during the treatment-period, two weeks post treatment, six months post treatment and 12 months post treatment.
Measures severity of generalised anxiety.
First week of treatment and then once a week during the treatment-period, two weeks post treatment, six months post treatment and 12 months post treatment.
Mini-Social Phobia Inventory (MINI-SPIN)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures clinical social phobia. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Agoraphobic Cognitions Questionnaire (ACQ)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures fearful cognitions associated with panic attacks and agoraphobia. The ACQ consists of 14 items which will be scored as a total scale in this study. worry. Respondents rates each item on a 5-point Likert scale consisting of never (1), Thought never occurs (2), Thought rarely occurs (3) Thought occurs during half of the times when I am nervous (4) Thought usually occurs (5) Thought always occurs when I am nervous. ACQ can be divided into two subscales: Loss of Control and Physical Concerns. Each of the subscales consists of 7 items.The total scores (or the subscales) are calculated by averaging the responses to the individual items composing that score. Higher scores indicates higher levels of fearful cognitions. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Satisfaction With Life Scale (SWLS)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures global cognitive judgements of one's life satisfacation as a whole, on a 5-item scale. Respondants rates how much they agree or disagree on a 7-pont scale ranging from (7) strongly agree to (1) strongly disagree, where higher scores indicates higher levels of life satisfaction. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Rosenberg Self-Esteem Scale (RSES)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Evaluates individual self-esteem. The scale is a ten item Likert scale with items answered on a four point scale, from (0) strongly agree to strongly disagree (3), where higher scores indicates higher self-esteem. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Alcohol Use Disorders Identification Test (AUDIT)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Measures alcohol consumption, drinking behaviors, and alcohol-related problems. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
Knowledge of CBT strategies (developed by the research group)
Tidsram: Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment
A brief 16-item questionnaire that measures explicit, declarative knowledge about core CBT-principles and therapeutic points. Higher scores indicates more knowledge. Change from baseline in symptoms two weeks post treatment and at 12 months post treatment.
Two weeks pre treatment, two weeks post treatment, six months post treatment and 12 months post treatment

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

8 februari 2018

Primärt slutförande (Faktisk)

20 maj 2018

Avslutad studie (Faktisk)

20 juni 2018

Studieregistreringsdatum

Först inskickad

14 februari 2018

Först inskickad som uppfyllde QC-kriterierna

20 februari 2018

Första postat (Faktisk)

22 februari 2018

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

9 augusti 2018

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

8 augusti 2018

Senast verifierad

1 augusti 2018

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • Dnr 2017/489-31.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Ångest

Prenumerera